| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/24/2009 | US20090317794 Biological indicator |
| 12/24/2009 | US20090317793 Microfluidic device and a microfluidic system and a method of performing a test |
| 12/24/2009 | US20090317792 Oil emulsions and methods for manufacture and use thereof |
| 12/24/2009 | US20090317791 Methods and apparatus for performing retention-time matching |
| 12/24/2009 | US20090317419 Tetramers |
| 12/24/2009 | US20090317415 Hpv vaccine comprising peptides from host cell proteins |
| 12/24/2009 | US20090317406 Phosphorylation of tau by abl |
| 12/24/2009 | US20090317392 Method of diagnosing small cell lung cancer |
| 12/24/2009 | US20090317391 Cancer Related Genes (PTPE) |
| 12/24/2009 | US20090317386 Transcription Infidelity, Detection and Uses Thereof |
| 12/24/2009 | US20090317371 Method, Composition, and Device, for the Treatment of Amylase Malfunctions / Inactivity in Association with Saccharides (Mainly Polysaccharides) Based Diseases |
| 12/24/2009 | US20090317365 Systems and methods for making hepatocytes from extrahepatic somatic stem cells and use thereof |
| 12/24/2009 | US20090317333 Protein kinase a reporters useful in high throughput assays |
| 12/24/2009 | US20090315987 Rapid detection of replicating cells |
| 12/24/2009 | DE112007002483T5 "Labor-auf-CD" Systeme mit magnetisch betriebenen Mikrorückschlagventilen und/oder magnetischer Immobilisierung "Lab-on-CD" systems with magnetically driven micro check valves and / or magnetic immobilization |
| 12/24/2009 | DE102008029174A1 Biosensor und Verfahren zum Bestimmen eines Gifts sowie Verwendungen des Biosensors Biosensor and method for determining a poison and uses of the biosensor |
| 12/24/2009 | DE102006031483B4 Zellulärer Pyrogentest Cellular pyrogen |
| 12/23/2009 | WO2009155559A1 Interferon alpha-induced pharmacodynamic markers |
| 12/23/2009 | WO2009155505A2 Microvesicle-based compositions and methods |
| 12/23/2009 | WO2009155455A1 Use of runx3 and mir-532-5p as cancer markers and therapeutic targets |
| 12/23/2009 | WO2009155443A2 Method and apparatus for sequencing data samples |
| 12/23/2009 | WO2009155310A1 Tumor suppression through plexin c1 |
| 12/23/2009 | WO2009155181A1 System and method for nucleic acids sequencing by phased synthesis |
| 12/23/2009 | WO2009155103A2 Compositions for use in identification of tick-borne pathogens |
| 12/23/2009 | WO2009155093A2 Compositions for use in identification of enteric bacterial pathogens |
| 12/23/2009 | WO2009155061A2 Compositions for use in identification of strains of e. coli o157:h7 |
| 12/23/2009 | WO2009155055A2 Methods of effecting wnt signaling through dkk structural analysis |
| 12/23/2009 | WO2009154999A2 Methods of identifying inhibitors of gene silencing in mammalian cells |
| 12/23/2009 | WO2009154860A2 Cripto-1 as a biomarker for cardiac hypoxia |
| 12/23/2009 | WO2009154790A2 Novel metastasis suppresor genes and uses thereof |
| 12/23/2009 | WO2009154733A2 Polymerase incorporation of non-standard nucleotides |
| 12/23/2009 | WO2009154710A2 Multi-dimensional fluid sensors and related detectors and methods |
| 12/23/2009 | WO2009154303A2 A method of manufacturing a mixture of amplified double-stranded nucleic acids comprising unknown sequence |
| 12/23/2009 | WO2009154265A1 Methods for production of cancer stem cell and cancer cell line |
| 12/23/2009 | WO2009154259A1 Primer for analysis of androgen receptor gene |
| 12/23/2009 | WO2009154247A1 Thermostable 1,5-anhydroglucitol dehydrogenase, and method for measurement of 1,5-anhydroglucitol by using the same |
| 12/23/2009 | WO2009154046A1 Surface-roughened high-density functional particle, method for producing the same, and method for processing target substance using the same |
| 12/23/2009 | WO2009154016A1 Method of evaluating pathogenicity of pathogenic bacterium, kit for evaluating pathogenicity and gene for evaluating pathogenicity |
| 12/23/2009 | WO2009153784A1 A polymer adapted to release bioactive agents in vivo, pharmaceutical composition and method of preparation thereof |
| 12/23/2009 | WO2009153783A1 Monitoring skin metabolism products for evaluating burn injury |
| 12/23/2009 | WO2009153779A2 Genotyping method and means thereof for use in traceability schemes |
| 12/23/2009 | WO2009153777A1 Electrode, method and system for determining an analyte in a liquid medium |
| 12/23/2009 | WO2009153775A2 Methods for distinguishing between specific types of lung cancers |
| 12/23/2009 | WO2009153774A2 Compositions and methods for prognosis of ovarian cancer |
| 12/23/2009 | WO2009153667A2 Method for the detection of ovarian cancer |
| 12/23/2009 | WO2009153660A2 Gene expression signatures for lung cancers |
| 12/23/2009 | WO2009153575A1 Methods of aiding in the diagnosis of prostate cancer |
| 12/23/2009 | WO2009153568A1 Method for determining dna copy number by competitive pcr |
| 12/23/2009 | WO2009153327A1 Detection of an analyte in aqueous media |
| 12/23/2009 | WO2009153293A1 Detection of an analyte in aqueous media |
| 12/23/2009 | WO2009153142A2 Microfluidic system |
| 12/23/2009 | WO2009153074A1 Biosensor and method for determining a toxin and uses for said biosensor |
| 12/23/2009 | WO2009153046A1 Marker of streptococcus anginosus / streptococcus constellatus (moac) and uses thereof |
| 12/23/2009 | WO2009152928A2 Method for the quantitative analysis of nucleic acids, markers therefor and their use |
| 12/23/2009 | WO2009152566A1 Auto-feedback loop biosensor |
| 12/23/2009 | WO2009152546A1 Dopamine-beta-hydroxylase genetic polymorphism and migraine |
| 12/23/2009 | WO2009135910A3 Modulators of mcam in the treatment of acne, of seborrhoeic dermatitis or of hyperseborrhoea |
| 12/23/2009 | WO2009135212A3 Selective 5' ligation tagging of rna |
| 12/23/2009 | WO2009133379A3 Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof |
| 12/23/2009 | WO2009132928A3 Molecular markers for cancer prognosis |
| 12/23/2009 | WO2009122448A3 Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm |
| 12/23/2009 | WO2009117346A3 System and method for determining the health of a subject using polymorphic risk markers |
| 12/23/2009 | WO2009117327A3 Compositions and methods for analysis of nucleic acid molecules during amplification reactions |
| 12/23/2009 | WO2009113794A3 Methods for screening initial codons providing desired expression levels of proteins, and methods for tuning expression and production of recombinant proteins |
| 12/23/2009 | WO2009111704A3 Fig4 gene mutations in neurodegeneration |
| 12/23/2009 | WO2009108921A3 Opto-fluidic nanoparticle detection apparatus |
| 12/23/2009 | WO2009108693A3 Composition and methods for rapid detection of hiv by loop- mediated isothermal amplification (lamp) |
| 12/23/2009 | WO2009086472A3 Use of methylation status of mint loci and tumor-related genes as a marker for melanoma and breast cancer |
| 12/23/2009 | WO2009073478A9 Tle3 as a marker for chemotherapy |
| 12/23/2009 | WO2009051776A3 Methods for detecting and differentiating mycobacterium genus and mycobacterium avium complex in a sample or culture |
| 12/23/2009 | WO2009042205A3 Fluorescent sensors for measuring cellular metabolism |
| 12/23/2009 | WO2009023343A3 Anti-bacterial drug targeting of genome maintenance interfaces |
| 12/23/2009 | WO2008130603A3 Increased ethanol production from xylose |
| 12/23/2009 | WO2008119190A8 Microfluidic platforms for genotyping |
| 12/23/2009 | WO2008084399A3 Associations of polymorphisms in the fibroblast growth factor 8 (fgf8) and its haplotypes with carcass quality, growth and feed efficiency in beef cattle |
| 12/23/2009 | WO2008058239A9 Spink1 as a prostate cancer marker and uses thereof |
| 12/23/2009 | EP2136206A1 Method and apparatus for determining substrate concentration and reagent for determining substrate concentration |
| 12/23/2009 | EP2135960A1 Genetic analysis for stratification of cancer risk by determining the allelic profile of the VDR-ApaI and CYP11B2 genes |
| 12/23/2009 | EP2135959A1 Use of (1R,2S,5R) 1,6-Diazabicyclo [3,2,1]octane-2-carboxamide, 7-oxo-6-(sulfooxy)-, monosodium salt as a diagnostic reagent for detecting serine beta-lactamases |
| 12/23/2009 | EP2135958A1 Method for evaluation of tissue preservation solution |
| 12/23/2009 | EP2135947A1 Antagonists of bacterial sequences |
| 12/23/2009 | EP2135943A1 Assay electrode having immobilized lipid/protein layers, methods of making the same and methods of using the same for luminescence test measurements |
| 12/23/2009 | EP2135877A1 Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof |
| 12/23/2009 | EP2135618A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 12/23/2009 | EP2135086A2 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors |
| 12/23/2009 | EP2135083A2 Test device, method and kit for phage detection |
| 12/23/2009 | EP2135080A2 Functional arrays for high throughput characterization of regulatory elements in untranslated regions of genes |
| 12/23/2009 | EP2135072A1 Device and method for the online control of drinking water on human tolerance within a drinking water supply network |
| 12/23/2009 | EP2135069A1 Serial siphon valves for fluidic or microfluidic devices |
| 12/23/2009 | EP2135064A1 Amperometric biosensor for histamine determination |
| 12/23/2009 | EP2134877A1 Determination of quality features in agricultural and horticultural crops |
| 12/23/2009 | EP2134876A1 Determining a predisposition to cancer by identification of genotype combinations of specific variants of the genes cyp1b1, brca2 and chek2 |
| 12/23/2009 | EP2134875A2 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| 12/23/2009 | EP2134874A1 Predicting post-treatment survival in cancer patients with micrornas |
| 12/23/2009 | EP2134873A2 Method of predicting a predisposition to qt prolongation |
| 12/23/2009 | EP2134870A1 Utility of snp markers associated with major soybean plant maturity and growth habit genomic regions |
| 12/23/2009 | EP2134869A2 Human diabetes susceptibility tnfrsf10a gene |
| 12/23/2009 | EP2134868A1 Human diabetes susceptibility tnfrsf10d gene |
| 12/23/2009 | EP2134867A1 Human diabetes susceptibility tnfrsf10c gene |
| 12/23/2009 | EP2134866A2 Human diabetes susceptibility tnfrsf10b gene |